Budesonide-formoterol 160-4.5 10.2GM
Ended Awarded
- Contract number
- SPE2DB25FE1KX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,536
Award facts
- Contract value 100% obligated
- $28,536.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,536.49 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Budesonide-Formoterol 160-4.5mg inhalers totaling 10.2 grams. This competitively awarded, firm fixed-price contract is not set-aside and specifies performance completion by September 29, 2025, with fulfillment from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply diverse pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA and its Medical Supply Chain. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for respiratory medication reflects the company's role in supporting military and veteran healthcare supply requirements through the DLA's pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DB25FE1KX?
SPE2DB25FE1KX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FE1KX worth?
The government has obligated $28,536 on SPE2DB25FE1KX.
Is contract SPE2DB25FE1KX an order under another contract?
Yes. SPE2DB25FE1KX is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE1KX competed?
The extent of competition for SPE2DB25FE1KX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award